Tag Archives: David J. Barton

Leafceuticals NuAxon Supercritical Ludlow Research Paul Pelosi Jr. Alternative Asset Summit Leafceuticals Freedom Leaf - financial conferences NuAxon otcqb Spanish Speaking WallStreet Research

Freedom Leaf Announces New Medical Advisory Board Members: Dr. Robert Melamede, Ph.D. and Dr. David Barton, MD., As It Plans For New Products In US and Internationally

Freedom Leaf Announces New Medical Advisory Board Members: Dr. Robert Melamede, Ph.D. and Dr. David Barton, MD., As It Plans For New Products In US and Internationally

LAS VEGAS, Nov. 28, 2016 /Weed Wire/ — Clifford J. Perry CEO of Freedom Leaf, Inc. “The Marijuana Legalization Company™” (OTC PINK: FRLF) announced today that Dr. Robert Melamede, Ph.D. and Dr. David J. Barton, MD are joining the company’s new medical advisory board.


Top